WO2005021038A3 - Agent for treating metabolic syndrome - Google Patents

Agent for treating metabolic syndrome Download PDF

Info

Publication number
WO2005021038A3
WO2005021038A3 PCT/EP2004/052111 EP2004052111W WO2005021038A3 WO 2005021038 A3 WO2005021038 A3 WO 2005021038A3 EP 2004052111 W EP2004052111 W EP 2004052111W WO 2005021038 A3 WO2005021038 A3 WO 2005021038A3
Authority
WO
WIPO (PCT)
Prior art keywords
agent
cholesterol
metabolic syndrome
treating metabolic
lowering substance
Prior art date
Application number
PCT/EP2004/052111
Other languages
German (de)
French (fr)
Other versions
WO2005021038A2 (en
Inventor
Guenther Beisel
Original Assignee
Guenther Beisel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10339354A external-priority patent/DE10339354A1/en
Priority claimed from DE20313224U external-priority patent/DE20313224U1/en
Application filed by Guenther Beisel filed Critical Guenther Beisel
Publication of WO2005021038A2 publication Critical patent/WO2005021038A2/en
Publication of WO2005021038A3 publication Critical patent/WO2005021038A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Abstract

The invention relates to an agent for treating metabolic syndrome and comprises at least one weight-reducing compound having a satiating effect and being capable of swelling or forming a gel, at least one cholesterol-lowering substance and/or an antidiabetic agent and optionally an antihypertonic agent. The inventive agent is characterized in that the ratio of the cholesterol-lowering substance to the compound having a satiating effect and/or the ratio of the antidiabetic agent to the compound having the satiating effect ranges between 9:1 and 1:9 if polymers are used as the cholesterol-lowering substance or the antidiabetic agent, and ranges between 1:1000 and 1:20 if pharmaceutically active substances are used as the cholesterol-lowering substance or the antidiabetic agent.
PCT/EP2004/052111 2003-08-27 2004-08-27 Agent for treating metabolic syndrome WO2005021038A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10339354A DE10339354A1 (en) 2003-08-27 2003-08-27 Synergistic composition for treating metabolic syndrome, comprises swellable or gel-forming satiating and weight reducing agent and hypocholesterolemic and/or antidiabetic agent
DE20313224U DE20313224U1 (en) 2003-08-27 2003-08-27 Synergistic composition for treating metabolic syndrome, comprises swellable or gel-forming anorectic agent for inducing satiation and polymeric or other hypocholesterolemic and/or antidiabetic agent
DE10339354.4 2003-08-27
DE20313224.6 2003-08-27

Publications (2)

Publication Number Publication Date
WO2005021038A2 WO2005021038A2 (en) 2005-03-10
WO2005021038A3 true WO2005021038A3 (en) 2005-04-14

Family

ID=34276514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/052111 WO2005021038A2 (en) 2003-08-27 2004-08-27 Agent for treating metabolic syndrome

Country Status (1)

Country Link
WO (1) WO2005021038A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007309225A1 (en) * 2006-10-20 2008-05-02 Dow Global Technologies Llc Method of preventing or treating metabolic syndrome

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
US4689219A (en) * 1983-06-29 1987-08-25 Reckitt & Colman Products Limited Pharmaceutical compositions
US4707376A (en) * 1980-10-29 1987-11-17 Yamanouchi Pharmaceutical Co., Ltd. Granular composition of difficult digestible polysaccharides
WO1991003170A1 (en) * 1989-08-31 1991-03-21 Paul Resmer Liquid, stable nutrient containing guar seed flour for oral or parenteral administration
EP0477161A1 (en) * 1990-09-19 1992-03-25 Instantina Nahrungsmittel Entwicklungs- und Produktions Gesellschaft m.b.H Dietetic food
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
DE10117185A1 (en) * 2001-03-02 2002-10-02 Trepel Friedrich Composition, useful for treating diabetes mellitus, comprises vegetable dietary fiber and alpha-glucosidase inhibitor administered in combination or immediately before or after
DE20219657U1 (en) * 2002-12-19 2003-02-27 Beisel Guenther Composition for treatment of obesity, comprising ginseng component and insoluble material swellable in gastrointestinal fluid

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
US4707376A (en) * 1980-10-29 1987-11-17 Yamanouchi Pharmaceutical Co., Ltd. Granular composition of difficult digestible polysaccharides
US4689219A (en) * 1983-06-29 1987-08-25 Reckitt & Colman Products Limited Pharmaceutical compositions
WO1991003170A1 (en) * 1989-08-31 1991-03-21 Paul Resmer Liquid, stable nutrient containing guar seed flour for oral or parenteral administration
EP0477161A1 (en) * 1990-09-19 1992-03-25 Instantina Nahrungsmittel Entwicklungs- und Produktions Gesellschaft m.b.H Dietetic food
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
DE10117185A1 (en) * 2001-03-02 2002-10-02 Trepel Friedrich Composition, useful for treating diabetes mellitus, comprises vegetable dietary fiber and alpha-glucosidase inhibitor administered in combination or immediately before or after
DE20219657U1 (en) * 2002-12-19 2003-02-27 Beisel Guenther Composition for treatment of obesity, comprising ginseng component and insoluble material swellable in gastrointestinal fluid

Also Published As

Publication number Publication date
WO2005021038A2 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
CA2329004A1 (en) Combination of insulin sensitizer with anorectic for treating or preventing diabetes
WO2003000226A3 (en) Pharmaceutical compositions containing polymer and drug assemblies
CA2274074A1 (en) Novel compounds with analgesic effect
WO2002064210A3 (en) Combination therapy comprising anti-diabetic and anticonvulsant agents
AU2003289888A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
WO2002009637A3 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
WO2006081273A8 (en) 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
AU2001247788A1 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
WO2003045878A8 (en) 2,w-diaminocarboxylic acid compounds
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
AU2963400A (en) Improved controlled release compositions and method
WO2005065456A3 (en) Active substance combinations having insecticidal properties
CA2368165A1 (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2002050067A3 (en) Pharmaceutical heterocyclic compounds
WO2003082926A3 (en) Antimicrobial polymer conjugates
WO2003067952A3 (en) Glucosamine-polyacrylate inter-polymer complex and applications thereof
CA2441461A1 (en) Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
AU2001294673A1 (en) Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
AU2003285281A1 (en) Topical application of curcumin for the treatment of peripheral neuropathy
WO2001091586A3 (en) Konjac mannan and ginseng compositions and methods and uses thereof
WO2005021038A3 (en) Agent for treating metabolic syndrome
WO2002009789A3 (en) Medical technical product, method for producing the same and providing the same for surgery
CA2417837A1 (en) Compositions for ameliorating attention-deficient/hyperactivity disorder
AU2003288974A1 (en) Compositions comprised of normal propyl bromide and 1,1,1,3,3-pentafluorobutane and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase